PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33069754-2	2021	Ceftriaxone (CEF) upregulates astrocytic GLT-1 expression/activity, which could counteract excessive glutamate levels and aggressive behavior induced by anabolic synthetic steroids such as nandrolone decanoate (ND).	Nandrolone Decanoate	189-209	solute carrier family 1 (glial high affinity glutamate transporter), member 2	Mus musculus	41-46
6367663-2	1984	The number of peripheral lymphocytes and monocytes, the PHA-blastoid transformation of peripheral lymphocytes and the IgG level were increased, and the beta 2-microglobulin level showed the tendency of decrease after the administration of Deca-Durabolin.	Nandrolone Decanoate	239-253	beta-2-microglobulin	Homo sapiens	152-172
6861993-4	1983	As far as the activity of liver cathepsins and beta-galactosidase is concerned retabolil was found to produce an opposite effect as compared to that of testosterone.	Nandrolone Decanoate	79-88	galactosidase, beta 1	Rattus norvegicus	47-65
33069754-2	2021	Ceftriaxone (CEF) upregulates astrocytic GLT-1 expression/activity, which could counteract excessive glutamate levels and aggressive behavior induced by anabolic synthetic steroids such as nandrolone decanoate (ND).	Nandrolone Decanoate	211-213	solute carrier family 1 (glial high affinity glutamate transporter), member 2	Mus musculus	41-46
32891681-8	2020	ND administration decreased the levels of brain-derived neurotrophic factor and neurotrophin-3 and reduced Na+,K+-ATPase activity in the hippocampus, striatum and prefrontal cortex.	Nandrolone Decanoate	0-2	brain derived neurotrophic factor	Mus musculus	42-75
32891681-8	2020	ND administration decreased the levels of brain-derived neurotrophic factor and neurotrophin-3 and reduced Na+,K+-ATPase activity in the hippocampus, striatum and prefrontal cortex.	Nandrolone Decanoate	0-2	neurotrophin 3	Mus musculus	80-94
28582442-4	2017	Simultaneously, nandrolone decanoate treatment resulted in diminution of NPY content both in blood (decreased serum levels) and in hippocampus (the significant decrease in NPY expression in all three investigated hippocampal regions-CA1, CA2/3 and DG).	Nandrolone Decanoate	16-36	neuropeptide Y	Rattus norvegicus	73-76
29336370-0	2018	Differences of Matrix Metalloproteinase 2 Expression between Left and Right Ventricles in Response to Nandrolone Decanoate and/or Swimming Training in Mice.	Nandrolone Decanoate	102-122	matrix metallopeptidase 2	Mus musculus	15-41
29336370-2	2018	We investigated the differences of MMP-2 expression between LV and RV in response to nandrolone decanoate (ND), swimming training (ST), and combined ND and ST (NS) in mice, based on their structural, functional, and biochemical characteristics.	Nandrolone Decanoate	85-105	matrix metallopeptidase 2	Mus musculus	35-40
33562928-0	2018	Enhanced Transport of Nandrolone Decanoate Drug by Human Serum Albumin in Presence of [BMIM]PF6 and [BMIM]BF4.	Nandrolone Decanoate	22-42	albumin	Homo sapiens	63-70
33562928-1	2018	The interaction of nandrolone decanoate drug dissolved in (2%) [BMIM]BF4 or [BMIM]PF6 with human serum albumin (HSA) at different temperatures in the range of 285-310 K was examined by fluorescence quenching.	Nandrolone Decanoate	19-39	albumin	Homo sapiens	97-110
29232412-0	2017	The opposite effects of nandrolone decanoate and exercise on anxiety levels in rats may involve alterations in hippocampal parvalbumin-positive interneurons.	Nandrolone Decanoate	24-44	parvalbumin	Rattus norvegicus	123-134
28902623-0	2017	Chronic endurance exercise antagonizes the cardiac UCP2 and UCP3 protein up-regulation induced by nandrolone decanoate.	Nandrolone Decanoate	98-118	uncoupling protein 2	Rattus norvegicus	51-55
28902623-0	2017	Chronic endurance exercise antagonizes the cardiac UCP2 and UCP3 protein up-regulation induced by nandrolone decanoate.	Nandrolone Decanoate	98-118	uncoupling protein 3	Rattus norvegicus	60-64
28902623-2	2017	METHODS: The present study examined whether the nandrolone decanoate (ND)-induced cardiac effects were mediated by changing the cardiac uncoupling protein 2 (UCP2) and 3 (UCP3) expression.	Nandrolone Decanoate	48-68	uncoupling protein 2	Rattus norvegicus	136-156
28902623-2	2017	METHODS: The present study examined whether the nandrolone decanoate (ND)-induced cardiac effects were mediated by changing the cardiac uncoupling protein 2 (UCP2) and 3 (UCP3) expression.	Nandrolone Decanoate	48-68	uncoupling protein 2	Rattus norvegicus	158-162
28902623-2	2017	METHODS: The present study examined whether the nandrolone decanoate (ND)-induced cardiac effects were mediated by changing the cardiac uncoupling protein 2 (UCP2) and 3 (UCP3) expression.	Nandrolone Decanoate	48-68	uncoupling protein 3	Rattus norvegicus	171-175
28902623-2	2017	METHODS: The present study examined whether the nandrolone decanoate (ND)-induced cardiac effects were mediated by changing the cardiac uncoupling protein 2 (UCP2) and 3 (UCP3) expression.	Nandrolone Decanoate	70-72	uncoupling protein 2	Rattus norvegicus	136-156
28902623-2	2017	METHODS: The present study examined whether the nandrolone decanoate (ND)-induced cardiac effects were mediated by changing the cardiac uncoupling protein 2 (UCP2) and 3 (UCP3) expression.	Nandrolone Decanoate	70-72	uncoupling protein 2	Rattus norvegicus	158-162
28902623-2	2017	METHODS: The present study examined whether the nandrolone decanoate (ND)-induced cardiac effects were mediated by changing the cardiac uncoupling protein 2 (UCP2) and 3 (UCP3) expression.	Nandrolone Decanoate	70-72	uncoupling protein 3	Rattus norvegicus	171-175
28582442-4	2017	Simultaneously, nandrolone decanoate treatment resulted in diminution of NPY content both in blood (decreased serum levels) and in hippocampus (the significant decrease in NPY expression in all three investigated hippocampal regions-CA1, CA2/3 and DG).	Nandrolone Decanoate	16-36	neuropeptide Y	Rattus norvegicus	172-175
28582442-4	2017	Simultaneously, nandrolone decanoate treatment resulted in diminution of NPY content both in blood (decreased serum levels) and in hippocampus (the significant decrease in NPY expression in all three investigated hippocampal regions-CA1, CA2/3 and DG).	Nandrolone Decanoate	16-36	carbonic anhydrase 1	Rattus norvegicus	233-236
28582442-4	2017	Simultaneously, nandrolone decanoate treatment resulted in diminution of NPY content both in blood (decreased serum levels) and in hippocampus (the significant decrease in NPY expression in all three investigated hippocampal regions-CA1, CA2/3 and DG).	Nandrolone Decanoate	16-36	carbonic anhydrase 2	Rattus norvegicus	238-250
29141576-3	2017	OBJECTIVE: The present study was conducted to investigate the impact of overuse of Nandrolone Decanoate (ND), an AAS, upon CYP enzyme activity and a CYP gene, belonging to CYP1 family.	Nandrolone Decanoate	83-103	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	123-126
28544314-0	2017	Low-intensity endurance exercise plus nandrolone decanoate modulates cardiac adiponectin and its receptors.	Nandrolone Decanoate	38-58	adiponectin, C1Q and collagen domain containing	Rattus norvegicus	77-88
29141576-3	2017	OBJECTIVE: The present study was conducted to investigate the impact of overuse of Nandrolone Decanoate (ND), an AAS, upon CYP enzyme activity and a CYP gene, belonging to CYP1 family.	Nandrolone Decanoate	83-103	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	149-152
27562815-1	2016	This study evaluated for the first time the effects of different doses of the anabolic steroid nandrolone decanoate (ND) on the expression of ovarian steroid receptors (AR, ER-alpha (ESR1) and ER-beta (ESR2)) and related sex hormones after treatment and recovery periods in adult rats.	Nandrolone Decanoate	95-115	estrogen receptor 1	Rattus norvegicus	173-181
29118945-5	2017	Methods: In this study, 24 New Zealand rabbits were randomly assigned to three groups receiving standard diet, atherogenic diet, and atherogenic diet plus once daily intramuscular injection of nandrolone decanoate as the PON1 inhibitor.	Nandrolone Decanoate	193-213	serum paraoxonase/arylesterase 1	Oryctolagus cuniculus	221-225
27562815-1	2016	This study evaluated for the first time the effects of different doses of the anabolic steroid nandrolone decanoate (ND) on the expression of ovarian steroid receptors (AR, ER-alpha (ESR1) and ER-beta (ESR2)) and related sex hormones after treatment and recovery periods in adult rats.	Nandrolone Decanoate	95-115	estrogen receptor 1	Rattus norvegicus	183-187
27562815-1	2016	This study evaluated for the first time the effects of different doses of the anabolic steroid nandrolone decanoate (ND) on the expression of ovarian steroid receptors (AR, ER-alpha (ESR1) and ER-beta (ESR2)) and related sex hormones after treatment and recovery periods in adult rats.	Nandrolone Decanoate	95-115	estrogen receptor 2	Rattus norvegicus	193-200
27562815-1	2016	This study evaluated for the first time the effects of different doses of the anabolic steroid nandrolone decanoate (ND) on the expression of ovarian steroid receptors (AR, ER-alpha (ESR1) and ER-beta (ESR2)) and related sex hormones after treatment and recovery periods in adult rats.	Nandrolone Decanoate	95-115	estrogen receptor 2	Rattus norvegicus	202-206
26370185-1	2016	The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men.	Nandrolone Decanoate	69-89	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	130-147
26370185-1	2016	The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men.	Nandrolone Decanoate	69-89	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	149-190
26370185-1	2016	The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men.	Nandrolone Decanoate	69-89	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	192-197
26370185-1	2016	The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men.	Nandrolone Decanoate	91-93	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	130-147
26370185-1	2016	The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men.	Nandrolone Decanoate	91-93	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	149-190
23805127-10	2013	Only UGT2B7 mRNA expression was significantly increased (1.8-folds) after incubation with nandrolone decanoate.	Nandrolone Decanoate	90-110	UDP glucuronosyltransferase family 2 member B7	Homo sapiens	5-11
26853157-0	2016	Atypical excretion profile and GC/C/IRMS findings may last for nine months after a single dose of nandrolone decanoate.	Nandrolone Decanoate	98-118	guanylate cyclase 2C	Homo sapiens	31-35
26853157-5	2016	The participants were genotyped for polymorphisms in PDE7B1 and UGT2B15 genes previously shown to influence the activation and inactivation of nandrolone decanoate.	Nandrolone Decanoate	143-163	UDP glucuronosyltransferase family 2 member B15	Homo sapiens	64-71
26165753-0	2015	Nandrolone decanoate induces cardiac and renal remodeling in female rats, without modification in physiological parameters: The role of ANP system.	Nandrolone Decanoate	0-20	natriuretic peptide A	Rattus norvegicus	136-139
25542992-7	2015	Results of the present study showed that taurine reversed nandrolone decanoate-induced perturbations in sperm characteristics, normalized serum testosterone level, and restored the activities of the key steroidogenic enzymes; 3beta-HSD, and 17beta-HSD.	Nandrolone Decanoate	58-78	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1	Rattus norvegicus	226-235
25542992-7	2015	Results of the present study showed that taurine reversed nandrolone decanoate-induced perturbations in sperm characteristics, normalized serum testosterone level, and restored the activities of the key steroidogenic enzymes; 3beta-HSD, and 17beta-HSD.	Nandrolone Decanoate	58-78	hydroxysteroid (17-beta) dehydrogenase 3	Rattus norvegicus	241-251
25300168-13	2014	Compared with erythropoietin (1 study, 27 participants), limited evidence was found to suggest that nandrolone decanoate can increase plasma total protein (MD 0.40 g/L, 95% CI 0.13 to 0.67), albumin (MD 0.20 g/L, 95% CI 0.01 to 0.39), and transferrin (MD 45.00 mg/dL, 95% CI 12.61 to 77.39) levels.	Nandrolone Decanoate	100-120	transferrin	Homo sapiens	239-250
25065671-2	2014	We studied the role played by oxidative stress in the apoptotic response caused by nandrolone decanoate in the kidneys of strength-trained male CD1 mice.	Nandrolone Decanoate	83-103	CD1 antigen complex	Mus musculus	144-147
24910615-0	2014	PDE7B is involved in nandrolone decanoate hydrolysis in liver cytosol and its transcription is up-regulated by androgens in HepG2.	Nandrolone Decanoate	21-41	phosphodiesterase 7B	Homo sapiens	0-5
24910615-8	2014	We show that PDE7B serves as a catalyst of the hydrolysis of testosterone enanthate and nandrolone decanoate in liver cytosol.	Nandrolone Decanoate	88-108	phosphodiesterase 7B	Homo sapiens	13-18
24910615-9	2014	The gene expression of PDE7B was significantly induced 3- and 5- fold after 2 h exposure to 1 muM testosterone enanthate and nandrolone decanoate, respectively.	Nandrolone Decanoate	125-145	phosphodiesterase 7B	Homo sapiens	23-28
24480470-0	2014	Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.	Nandrolone Decanoate	37-57	growth hormone receptor	Rattus norvegicus	130-141
24480470-0	2014	Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.	Nandrolone Decanoate	37-57	insulin-like growth factor 1	Rattus norvegicus	143-148
24480470-0	2014	Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.	Nandrolone Decanoate	37-57	insulin-like growth factor 2	Rattus norvegicus	154-159
24480470-2	2014	Among AAS users it is common to combine the AAS nandrolone decanoate (ND), with intake of growth hormone (GH) and a connection between gonadal steroids and the GH system has been suggested.	Nandrolone Decanoate	70-72	gonadotropin releasing hormone receptor	Rattus norvegicus	90-104
24480470-2	2014	Among AAS users it is common to combine the AAS nandrolone decanoate (ND), with intake of growth hormone (GH) and a connection between gonadal steroids and the GH system has been suggested.	Nandrolone Decanoate	70-72	gonadotropin releasing hormone receptor	Rattus norvegicus	160-162
24319735-4	2013	In Wistar rats, retabolil increased the total cell count and the content of CD4 (+) thymocytes, but reduced the number of CD8 (+) cells.	Nandrolone Decanoate	16-25	Cd4 molecule	Rattus norvegicus	76-79
26187709-0	2015	Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.	Nandrolone Decanoate	40-60	NFE2 like bZIP transcription factor 2	Rattus norvegicus	167-171
26187709-0	2015	Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.	Nandrolone Decanoate	40-60	heme oxygenase 1	Rattus norvegicus	172-176
26187709-0	2015	Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.	Nandrolone Decanoate	40-60	TNF receptor superfamily member 1A	Rattus norvegicus	209-214
24630363-4	2014	Furthermore, long-term treatment of orchiectomized hSOD1-G93A mice with nandrolone decanoate (ND), an anabolic androgenic steroid, worsened disease manifestations.	Nandrolone Decanoate	72-92	superoxide dismutase 1	Homo sapiens	51-56
24630363-4	2014	Furthermore, long-term treatment of orchiectomized hSOD1-G93A mice with nandrolone decanoate (ND), an anabolic androgenic steroid, worsened disease manifestations.	Nandrolone Decanoate	94-96	superoxide dismutase 1	Homo sapiens	51-56
24630363-8	2014	Notably, stimulation with ND promoted the recruitment of endogenous androgen receptor into biochemical complexes that were insoluble in sodium dodecyl sulfate, a finding consistent with protein aggregation.	Nandrolone Decanoate	26-28	androgen receptor	Mus musculus	68-85
24937439-1	2014	Nandrolone decanoate (ND), an anabolic androgenic steroid (AAS), induces an aggressive phenotype by mechanisms involving glutamate-induced N-methyl-d-aspartate receptor (NMDAr) hyperexcitability.	Nandrolone Decanoate	0-20	glutamate receptor, ionotropic, NMDA1 (zeta 1)	Mus musculus	139-168
24937439-1	2014	Nandrolone decanoate (ND), an anabolic androgenic steroid (AAS), induces an aggressive phenotype by mechanisms involving glutamate-induced N-methyl-d-aspartate receptor (NMDAr) hyperexcitability.	Nandrolone Decanoate	0-20	glutamate receptor, ionotropic, NMDA1 (zeta 1)	Mus musculus	170-175
24937439-1	2014	Nandrolone decanoate (ND), an anabolic androgenic steroid (AAS), induces an aggressive phenotype by mechanisms involving glutamate-induced N-methyl-d-aspartate receptor (NMDAr) hyperexcitability.	Nandrolone Decanoate	22-24	glutamate receptor, ionotropic, NMDA1 (zeta 1)	Mus musculus	139-168
24937439-1	2014	Nandrolone decanoate (ND), an anabolic androgenic steroid (AAS), induces an aggressive phenotype by mechanisms involving glutamate-induced N-methyl-d-aspartate receptor (NMDAr) hyperexcitability.	Nandrolone Decanoate	22-24	glutamate receptor, ionotropic, NMDA1 (zeta 1)	Mus musculus	170-175
23287648-0	2013	Nandrolone decanoate determines cardiac remodelling and injury by an imbalance in cardiac inflammatory cytokines and ACE activity, blunting of the Bezold-Jarisch reflex, resulting in the development of hypertension.	Nandrolone Decanoate	0-20	angiotensin I converting enzyme	Rattus norvegicus	117-120
23210612-0	2013	DNA damage, p53, Ki-67 and COX-2 expression in rat tongue cells exposed to nandrolone decanoate.	Nandrolone Decanoate	75-95	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	27-32
23210612-6	2013	Significant increase in immunoexpression of Ki-67, p53, COX-2 proteins was detected in the groups treated with nandrolone decanoate during 15 and 30 days, when compared to their respective controls.	Nandrolone Decanoate	111-131	Wistar clone pR53P1 p53 pseudogene	Rattus norvegicus	51-54
23210612-6	2013	Significant increase in immunoexpression of Ki-67, p53, COX-2 proteins was detected in the groups treated with nandrolone decanoate during 15 and 30 days, when compared to their respective controls.	Nandrolone Decanoate	111-131	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	56-61
23210612-7	2013	A positive correlation between immunoexpression of p53 and COX-2 protein was detected following nandrolone decanoate exposure.	Nandrolone Decanoate	96-116	Wistar clone pR53P1 p53 pseudogene	Rattus norvegicus	51-54
23210612-7	2013	A positive correlation between immunoexpression of p53 and COX-2 protein was detected following nandrolone decanoate exposure.	Nandrolone Decanoate	96-116	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	59-64
23210612-9	2013	Our results suggest that nandrolone decanoate was able to alter the expression of cell cycle-related proteins, as well as to induce genetic damage and COX-2 immunoexpression in tongue cells of Wistar rats.	Nandrolone Decanoate	25-45	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	151-156
23063952-0	2013	Neuroprotective effect of erythropoietin on nandrolone decanoate-induced brain injury in rats.	Nandrolone Decanoate	44-64	erythropoietin	Rattus norvegicus	26-40
23063952-3	2013	The aim of the present study is to investigate the neuroprotective effects of EPO in the hippocampus, parietal cortex and prefrontal cortex, in brain damage due to nandrolone decanoate.	Nandrolone Decanoate	164-184	erythropoietin	Rattus norvegicus	78-81
22290321-2	2012	The main objective of the present study was to investigate the effects of nandrolone decanoate on matrix metalloprotease (MMP-2) activity and protein level in the left ventricle (LV) of rats after 7 weeks of mechanical load exercise.	Nandrolone Decanoate	74-94	matrix metallopeptidase 2	Rattus norvegicus	122-127
20205638-0	2010	Nandrolone decanoate enhances the activities of cholanthrene induced glutathione-s-transferase in liver tissue of albino mice.	Nandrolone Decanoate	0-20	hematopoietic prostaglandin D synthase	Mus musculus	69-94
19703475-0	2009	Effects of swimming and nandrolone decanoate treatment on vas deferens response to norepinephrine.	Nandrolone Decanoate	24-44	arginine vasopressin	Rattus norvegicus	58-61
20043618-0	2009	Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.	Nandrolone Decanoate	0-20	erythropoietin	Homo sapiens	42-56
19782718-0	2009	Nandrolone decanoate administration elevates hippocampal prodynorphin mRNA expression and impairs Morris water maze performance in male rats.	Nandrolone Decanoate	0-20	prodynorphin	Rattus norvegicus	57-69
19601874-0	2009	Enhanced hepatic and kidney cytochrome p-450 activities in nandrolone decanoate treated albino mice.	Nandrolone Decanoate	59-79	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	28-44
19601874-5	2009	However, effect of nandrolone decanoate, most commonly abused anabolic steroid, on cytochrome P-450 activity is still fragmentary.	Nandrolone Decanoate	19-39	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	83-99
19601874-11	2009	From the above observation, nandrolone decanoate can be suggested as a potent inducer of cytochrome P-450 activity like other anabolic steroids.	Nandrolone Decanoate	28-48	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	89-105
15949641-0	2005	The impact of chronic nandrolone decanoate administration on the NK1 receptor density in rat brain as determined by autoradiography.	Nandrolone Decanoate	22-42	tachykinin receptor 1	Rattus norvegicus	65-77
18539264-3	2008	The aim of the present study was to investigate whether the same dose regimen of nandrolone decanoate may affect the activities of the dopamine-metabolizing enzymes monoamine oxidases A and B (MAO-A and MAO-B).	Nandrolone Decanoate	81-101	monoamine oxidase A	Rattus norvegicus	193-198
18539264-3	2008	The aim of the present study was to investigate whether the same dose regimen of nandrolone decanoate may affect the activities of the dopamine-metabolizing enzymes monoamine oxidases A and B (MAO-A and MAO-B).	Nandrolone Decanoate	81-101	monoamine oxidase B	Rattus norvegicus	203-208
18539264-7	2008	3 mg/kg of nandrolone decanoate significantly reduced the activity of both MAO-A and -B in the caudate putamen.	Nandrolone Decanoate	11-31	monoamine oxidase A	Rattus norvegicus	75-87
18539264-8	2008	15 mg/kg of nandrolone decanoate significantly reduced the activity of MAO-A in the amygdala and increased the gene transcript level of MAO-B in the substantia nigra.	Nandrolone Decanoate	12-32	monoamine oxidase A	Rattus norvegicus	71-76
18539264-8	2008	15 mg/kg of nandrolone decanoate significantly reduced the activity of MAO-A in the amygdala and increased the gene transcript level of MAO-B in the substantia nigra.	Nandrolone Decanoate	12-32	monoamine oxidase B	Rattus norvegicus	136-141
15949641-3	2005	An overall tendency of attenuation of NK1 receptor density was observed after completed treatment with nandrolone decanoate.	Nandrolone Decanoate	103-123	tachykinin receptor 1	Rattus norvegicus	38-50
15149150-21	2004	In conclusion, combination therapy with EPO, nandrolone decanoate and low-dose methylprednisolone may be effective as an alternative treatment for RBC transfusion-dependent patients with RA unresponsive to EPO administration alone.	Nandrolone Decanoate	45-65	erythropoietin	Homo sapiens	206-209
14746881-0	2004	Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration.	Nandrolone Decanoate	79-99	solute carrier family 6 member 3	Rattus norvegicus	10-30
14746881-3	2004	Recently chronic administration with nandrolone decanoate to male rats has been shown to increase the dopamine transporter (DAT) density in the striatum visualised in vivo by positron emission tomography.	Nandrolone Decanoate	37-57	solute carrier family 6 member 3	Rattus norvegicus	102-122
14746881-3	2004	Recently chronic administration with nandrolone decanoate to male rats has been shown to increase the dopamine transporter (DAT) density in the striatum visualised in vivo by positron emission tomography.	Nandrolone Decanoate	37-57	solute carrier family 6 member 3	Rattus norvegicus	124-127
14746881-6	2004	Two weeks of nandrolone decanoate administration at the supra-therapeutic doses 1, 5 and 15 mg/kg per day increased DAT density in the caudate putamen at all three doses.	Nandrolone Decanoate	13-33	solute carrier family 6 member 3	Rattus norvegicus	116-119
14556075-0	2003	RhoA induction by functional overload and nandrolone decanoate administration in rat skeletal muscle.	Nandrolone Decanoate	42-62	ras homolog family member A	Rattus norvegicus	0-4
12571141-0	2003	Overload-induced androgen receptor expression in the aged rat hindlimb receiving nandrolone decanoate.	Nandrolone Decanoate	81-101	androgen receptor	Rattus norvegicus	17-34
12965238-0	2003	Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels.	Nandrolone Decanoate	28-48	proopiomelanocortin	Homo sapiens	70-89
12965238-3	2003	In order to distinguish changes induced by the steroid treatment per se from those resulting from the reduced food intake and growth rate, we also compared the effect of nandrolone decanoate on AgRP and POMC mRNA expression with both normally fed, and food restricted control groups.	Nandrolone Decanoate	170-190	agouti related neuropeptide	Homo sapiens	194-198
12965238-3	2003	In order to distinguish changes induced by the steroid treatment per se from those resulting from the reduced food intake and growth rate, we also compared the effect of nandrolone decanoate on AgRP and POMC mRNA expression with both normally fed, and food restricted control groups.	Nandrolone Decanoate	170-190	proopiomelanocortin	Homo sapiens	203-207
12943056-1	2003	AIM: To study the effect of short-term and long-term treatment with retabolil, an androgenic anabolic steroid, on the activity of the enzymes ATP and LPL in rat cardiomyocytes and adipocytes.	Nandrolone Decanoate	68-77	lipoprotein lipase	Rattus norvegicus	150-153
12943056-6	2003	In the rats given a long-term treatment with retabolil, the enzyme-histochemical reaction for ATP was better expressed while that for LPL was weak.	Nandrolone Decanoate	45-54	lipoprotein lipase	Rattus norvegicus	134-137
12943056-7	2003	The subcutaneous adipose tissue of the long-term retabolil-treated animals contained some adipocytes that expressed positive LPL and ATP activity.	Nandrolone Decanoate	49-58	lipoprotein lipase	Rattus norvegicus	125-128
11876781-0	2002	The anabolic androgenic steroid, nandrolone decanoate, increases the density of Fos-like immunoreactive neurons in limbic regions of guinea-pig brain.	Nandrolone Decanoate	33-53	proto-oncogene c-Fos	Cavia porcellus	80-83
12298427-11	2002	In comparison between male and female groups, weekly doses of epoetin and nandrolone decanoate were significantly greater in the female group than the male group (epoetin: 50.66 +/- 6.23 vs 61.18 +/- 8.76 U/kg/week, nandrolone decanoate: 1.69 +/- 0.2 vs 2.04 +/- 0.29 mg/kg/week, p < 0.05).	Nandrolone Decanoate	74-94	erythropoietin	Homo sapiens	163-170
15758466-0	2001	Interaction between nandrolone decanoate and calcitonin in bone formation markers (osteocalcin and bone specific alkaline phosphatase) and IGF-I in rats.	Nandrolone Decanoate	20-40	bone gamma-carboxyglutamate protein	Rattus norvegicus	83-94
15758466-3	2001	Our investigation was intended to assess the effect of nandrolone decanoate and calcitonin treatment on biochemical markers of bone formation (bone alkaline phosphatase - osteocalcin) and insulin-like growth factor-I in rats.	Nandrolone Decanoate	55-75	insulin-like growth factor 1	Rattus norvegicus	148-216
15758466-9	2001	Nandrolone decanoate and calcitonin have a mild but significant effect on insulin-like growth factor-I without affecting osteocalcin levels, while calcitonin alone decreases the BALP levels.	Nandrolone Decanoate	0-20	insulin-like growth factor 1	Rattus norvegicus	74-102
12544632-8	2003	A significantly higher number of c-fos expressing neurons were observed in the periventricular region of the steroid-2 than the control and vehicle groups, indicating enhanced neuronal activity after nandrolone decanoate treatment.	Nandrolone Decanoate	200-220	Fos proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	33-38
10642358-0	2000	Nandrolone decanoate does not enhance training effects but increases IGF-I mRNA in rat diaphragm.	Nandrolone Decanoate	0-20	insulin-like growth factor 1	Rattus norvegicus	69-74
11074357-4	2000	Nandrolone decanoate (ND), an estrene derivative, but not stanozolol (ST), a derivative of the androstane series, up-regulated the levels of HSP72 and changed the proportions of various charge variants of the cytosolic HSP70s in sedentary and exercise-trained rats, exclusively in fast-twitch fibres.	Nandrolone Decanoate	0-20	heat shock protein family A (Hsp70) member 1A	Rattus norvegicus	141-146
11074357-4	2000	Nandrolone decanoate (ND), an estrene derivative, but not stanozolol (ST), a derivative of the androstane series, up-regulated the levels of HSP72 and changed the proportions of various charge variants of the cytosolic HSP70s in sedentary and exercise-trained rats, exclusively in fast-twitch fibres.	Nandrolone Decanoate	0-20	heat shock protein family A (Hsp70) member 1B	Rattus norvegicus	219-224
11074357-4	2000	Nandrolone decanoate (ND), an estrene derivative, but not stanozolol (ST), a derivative of the androstane series, up-regulated the levels of HSP72 and changed the proportions of various charge variants of the cytosolic HSP70s in sedentary and exercise-trained rats, exclusively in fast-twitch fibres.	Nandrolone Decanoate	22-24	heat shock protein family A (Hsp70) member 1A	Rattus norvegicus	141-146
11074357-6	2000	The reported results indicate that, by up-regulating the expression levels of HSP72 in fast-twitch fibres, nandrolone decanoate could contribute to improving the tolerance of skeletal muscle to high-intensity training.	Nandrolone Decanoate	107-127	heat shock protein family A (Hsp70) member 1A	Rattus norvegicus	78-83
10642358-11	2000	We conclude that administration of nandrolone decanoate did not enhance the previously observed training effects in rat diaphragm, although it increased the IGF-I mRNA expression levels.	Nandrolone Decanoate	35-55	insulin-like growth factor 1	Rattus norvegicus	157-162
10434944-7	1999	In conclusion, the treatment of mature stallions with nandrolone decanoate caused a decrease in the secretion of ir-inhibin and testosterone from the testis, the depletion of the number of Leydig cells and a decrease below detectable amounts of inhibin alpha-subunit and steroidogenesis enzymes.	Nandrolone Decanoate	54-74	inhibin subunit alpha	Homo sapiens	245-266
10048900-10	1999	In summary, nandrolone decanoate therapy in the absence of an exercise program in borderline hypogonadal men with AWS caused substantial nitrogen retention compared with placebo, similar in extent to the nitrogen retention previously achieved with recombinant growth hormone.	Nandrolone Decanoate	12-32	growth hormone 1	Homo sapiens	260-274
9350070-0	1997	Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.	Nandrolone Decanoate	33-46	lipoprotein(a)	Homo sapiens	57-62
9350070-2	1997	We evaluated the effect of nandrolone decanoate, a testosterone-derived synthetic anabolic steroid, on serum Lp(a), lipids and lipoproteins in 19 postmenopausal women who were given parenteral nandrolone decanoate (Decadurabolin) once a week for 3 weeks.	Nandrolone Decanoate	27-47	lipoprotein(a)	Homo sapiens	109-114
2375235-6	1990	The serum concentration of vitamin D-binding protein and 1,25(OH)2D increased transiently during estradiol and norethisterone acetate treatment and vitamin D-binding protein decreased transiently during nandrolone decanoate treatment.	Nandrolone Decanoate	203-223	GC vitamin D binding protein	Homo sapiens	148-173
34261436-3	2021	The aim of this study was to investigate the effects of four-week administration of nandrolone decanoate and swimming training alone or in combination on morphometric parameters, androgen receptor (AR) and redox state in testicle tissue.	Nandrolone Decanoate	84-104	androgen receptor	Rattus norvegicus	179-196
34261436-3	2021	The aim of this study was to investigate the effects of four-week administration of nandrolone decanoate and swimming training alone or in combination on morphometric parameters, androgen receptor (AR) and redox state in testicle tissue.	Nandrolone Decanoate	84-104	androgen receptor	Rattus norvegicus	198-200
9100047-0	1997	Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.	Nandrolone Decanoate	0-20	lipoprotein(a)	Homo sapiens	35-49
9100047-4	1997	Other lipid changes induced by nandrolone decanoate were an increase in the concentrations of apolipoprotein B (P < 0.02, ANOVA) and triglyceride (P = NS, ANOVA) and a decrease of high-density lipoprotein (HDL) cholesterol (P < 0.001, ANOVA) and apolipoprotein A-I (P = NS, ANOVA).	Nandrolone Decanoate	31-51	apolipoprotein B	Homo sapiens	94-110
9100047-4	1997	Other lipid changes induced by nandrolone decanoate were an increase in the concentrations of apolipoprotein B (P < 0.02, ANOVA) and triglyceride (P = NS, ANOVA) and a decrease of high-density lipoprotein (HDL) cholesterol (P < 0.001, ANOVA) and apolipoprotein A-I (P = NS, ANOVA).	Nandrolone Decanoate	31-51	apolipoprotein A1	Homo sapiens	252-270
7889180-8	1995	Over the 1-year therapeutic intervention period, an increase in IGF-I of 13-15% (p < 0.05) was seen in the nandrolone decanoate-treated group.	Nandrolone Decanoate	110-130	insulin like growth factor 1	Homo sapiens	64-69
7477614-9	1995	The serum erythropoietin returned to basal levels 6 weeks after the last dose of nandrolone decanoate (7.7 +/- 5.4 mIU/ml).	Nandrolone Decanoate	81-101	erythropoietin	Homo sapiens	10-24
1491396-0	1992	Effect of calcitonin or the anabolic steroid Decadurabolin on serum beta 2 microglobulin in osteoporotic postmenopausal women.	Nandrolone Decanoate	45-58	beta-2-microglobulin	Homo sapiens	68-88